Underwriter Aegis will help raise funds for general corporate purposes
By Devika Patel
Knoxville, Tenn., Aug. 15 - Neuralstem, Inc. said it priced its $2.4 million public offering of stock with a $360,000 greenshoe. The deal was announced on Aug. 3.
The company will sell 6 million common shares at $0.40 apiece. The per-share purchase price is a 39.39% discount to the closing share price of $0.66 on Aug. 14.
Aegis Capital Corp. is the bookrunner.
Settlement is expected on Aug. 20.
Proceeds will be used for general corporate purposes, including working capital, product development and capital expenditures.
Based in Rockville, Md., Neuralstem develops technologies to transplant human neural stem cells.
| Issuer: | Neuralstem, Inc.
|
| Issue: | Common stock
|
| Amount: | $2.4 million
|
| Greenshoe: | $360,000
|
| Shares: | 6 million
|
| Price: | $0.40
|
| Warrants: | No
|
| Bookrunner: | Aegis Capital Corp.
|
| Announcement date: | Aug. 3
|
| Pricing date: | Aug. 15
|
| Settlement date: | Aug. 20
|
| Stock symbol: | NYSE AMEX: CUR
|
| Stock price: | $0.66 at close Aug. 14
|
| Market capitalization: | $27.65 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
